de novo variant risk_factor_for psychiatric disorders
Evidence from:
primary |
all sources
Evidence (2 sources)
first genome-wide studies of de novo mutations in psychiatric disorders revealed a role for rare (<0.1%) de novo CNVs in ASD
confidence: 0.85
Some fraction of disease alleles occurs as de novo mutations... de novo mutations have consistently shown the strongest genetic effect.
confidence: 0.90